Director/PDMR Shareholding (5436Y)
March 01 2012 - 12:31PM
UK Regulatory
TIDMUDG
RNS Number : 5436Y
United Drug PLC
01 March 2012
Notification of Transactions of (1) Persons Discharging
Managerial Responsibility and (2) Persons closely associated with
Persons Discharging Managerial Responsibility
This form is intended for use by an issuer making a notification
required by Rules 7.2 and 7.3 of the Central Bank of Ireland's
Market Abuse Rules in relation to a person falling within either of
the above categories of individual. These categories are defined in
Regulation 12 (8) of the Market Abuse (Directive 2003/6/EC)
Regulations 2005 and are detailed as part of this form.
All relevant boxes should be completed in block capital
letters.
Name of the Issuer Name of person discharging managerial
responsibilities
1 UNITED DRUG PLC 2 MR. HUGH FRIEL
3 State whether notification 4 Indicate whether the notification
relates to a person closely is in respect of a holding of
associated with a person the person referred to in 2 or
discharging managerial responsibilities 3 above or in respect of a non-beneficial
named in 2 and identify the interest
connected person
N/A
RELATES TO PERSON NAMED IN 2
----------------------------------------- --- -------------------------------------------
Description of shares or
derivatives or other financial Name of registered shareholder(s)
instruments linked to them and, if more than one, number
of shares or derivatives or other
financial instruments linked to
them, held by each shareholder
ORDINARY SHARES OF EUR0.05
5 EACH 6 MR. HUGH FRIEL
----------------------------------------- --- -------------------------------------------
State the nature of the transaction
Number of shares, derivatives
PARTICIPATION IN DIVIDEND or other financial instruments
REINVESTMENT PLAN RELATING linked to them acquired
TO FINAL DIVIDEND FOR YEAR
7 END 30 SEPTEMBER 2011 8 466
----------------------------------------- --- -------------------------------------------
Price per share or derivative
Number of shares, derivatives or other financial instrument
or other financial instruments linked to them or value of transaction
linked to them disposed of
9 N/A 10 EUR2.198226
----------------------------------------- --- -------------------------------------------
Date and place of transaction
Date issuer informed of transaction
20 FEBRUARY - 1 MARCH 2012
11 DUBLIN, LONDON 12 1 MARCH 2012
----------------------------------------- --- -------------------------------------------
Name of contact and telephone
number for queries
Any additional information
KAREN GEOGHEGAN
13 N/A 14 + 353 1 463 7720
----------------------------------------- --- -------------------------------------------
Name and signature of duly designated officer of issuer responsible
for making notification
KAREN GEOGHEGAN_____________________________
Date of notification 1 MARCH 2012___________________
--- -------------------------------------------------------------------------------------------
The following information is required under the Irish Stock
Exchange's Listing Rule 6.10. An issuer is not required to submit
the following information to the Central Bank of Ireland.
15 Description of class of 16 Percentage of issued class acquired
share (treasury shares of that class should
not be taken into account when calculating
percentage)
ORDINARY SHARES 0.00019%
Percentage of issued class Total holding following notification
disposed (treasury shares and total percentage holding following
of that class should not notification (any treasury shares
be taken into account when should not be taken into account
calculating percentage) when calculating percentage)
17 N/A 18 21,241 (0.0088%)
---------------------------- --- --------------------------------------------
If a person discharging managerial responsibilities has been
granted options by the issuer, please complete the following
boxes:
Date of grant Period during which or date on which
it can be exercised
19 N/A 20 N/A
Description of shares involved (class
Total amount paid (if any) and number)
for grant of the option
21 N/A 22 N/A
--------------------------------- --- -----------------------------------------
23 Exercise price (if fixed 24 Total number of shares over which
at time of grant) or indication options are held following notification
that the price is to be
fixed at the time of exercise
N/A
N/A
--------------------------------- --- -----------------------------------------
Notification of Transactions of (1) Persons Discharging
Managerial Responsibility and (2) Persons closely associated with
Persons Discharging Managerial Responsibility
This form is intended for use by an issuer making a notification
required by Rules 7.2 and 7.3 of the Central Bank of Ireland's
Market Abuse Rules in relation to a person falling within either of
the above categories of individual. These categories are defined in
Regulation 12 (8) of the Market Abuse (Directive 2003/6/EC)
Regulations 2005 and are detailed as part of this form.
All relevant boxes should be completed in block capital
letters.
Name of the Issuer Name of person discharging managerial
responsibilities
1 UNITED DRUG PLC 2 MR. LIAM LOGUE
3 State whether notification 4 Indicate whether the notification
relates to a person closely is in respect of a holding of
associated with a person the person referred to in 2 or
discharging managerial responsibilities 3 above or in respect of a non-beneficial
named in 2 and identify the interest
connected person
N/A
RELATES TO PERSON NAMED IN 2
----------------------------------------- --- -------------------------------------------
Description of shares or
derivatives or other financial Name of registered shareholder(s)
instruments linked to them and, if more than one, number
of shares or derivatives or other
financial instruments linked to
them, held by each shareholder
ORDINARY SHARES OF EUR0.05
5 EACH 6 MR. LIAM LOGUE
----------------------------------------- --- -------------------------------------------
State the nature of the transaction
Number of shares, derivatives
PARTICIPATION IN DIVIDEND or other financial instruments
REINVESTMENT PLAN RELATING linked to them acquired
TO FINAL DIVIDEND FOR YEAR
7 END 30 SEPTEMBER 2011 8 327
----------------------------------------- --- -------------------------------------------
Price per share or derivative
Number of shares, derivatives or other financial instrument
or other financial instruments linked to them or value of transaction
linked to them disposed of
9 N/A 10 EUR2.198226
----------------------------------------- --- -------------------------------------------
Date and place of transaction
Date issuer informed of transaction
20 FEBRUARY - 1 MARCH 2012
11 DUBLIN, LONDON 12 1 MARCH 2012
----------------------------------------- --- -------------------------------------------
Name of contact and telephone
number for queries
Any additional information
KAREN GEOGHEGAN
13 N/A 14 + 353 1 463 7720
----------------------------------------- --- -------------------------------------------
Name and signature of duly designated officer of issuer responsible
for making notification
KAREN GEOGHEGAN_____________________________
Date of notification 1 MARCH 2012___________________
--- -------------------------------------------------------------------------------------------
The following information is required under the Irish Stock
Exchange's Listing Rule 6.10. An issuer is not required to submit
the following information to the Central Bank of Ireland.
15 Description of class of 16 Percentage of issued class acquired
share (treasury shares of that class should
not be taken into account when calculating
percentage)
ORDINARY SHARES 0.00013%
Percentage of issued class Total holding following notification
disposed (treasury shares and total percentage holding following
of that class should not notification (any treasury shares
be taken into account when should not be taken into account
calculating percentage) when calculating percentage)
17 N/A 18 19,814 (0.0083%)
---------------------------- --- --------------------------------------------
If a person discharging managerial responsibilities has been
granted options by the issuer, please complete the following
boxes:
Date of grant Period during which or date on which
it can be exercised
19 N/A 20 N/A
Description of shares involved (class
Total amount paid (if any) and number)
for grant of the option
21 N/A 22 N/A
--------------------------------- --- -----------------------------------------
23 Exercise price (if fixed 24 Total number of shares over which
at time of grant) or indication options are held following notification
that the price is to be
fixed at the time of exercise
N/A
N/A
--------------------------------- --- -----------------------------------------
Notification of Transactions of (1) Persons Discharging
Managerial Responsibility and (2) Persons closely associated with
Persons Discharging Managerial Responsibility
This form is intended for use by an issuer making a notification
required by Rules 7.2 and 7.3 of the Central Bank of Ireland's
Market Abuse Rules in relation to a person falling within either of
the above categories of individual. These categories are defined in
Regulation 12 (8) of the Market Abuse (Directive 2003/6/EC)
Regulations 2005 and are detailed as part of this form.
All relevant boxes should be completed in block capital
letters.
Name of the Issuer Name of person discharging managerial
responsibilities
1 UNITED DRUG PLC 2 MR. BARRY MCGRANE
3 State whether notification 4 Indicate whether the notification
relates to a person closely is in respect of a holding of
associated with a person the person referred to in 2 or
discharging managerial responsibilities 3 above or in respect of a non-beneficial
named in 2 and identify the interest
connected person
N/A
RELATES TO PERSON NAMED IN 2
----------------------------------------- --- -------------------------------------------
Description of shares or
derivatives or other financial Name of registered shareholder(s)
instruments linked to them and, if more than one, number
of shares or derivatives or other
financial instruments linked to
them, held by each shareholder
ORDINARY SHARES OF EUR0.05
5 EACH 6 MR. BARRY MCGRANE
----------------------------------------- --- -------------------------------------------
State the nature of the transaction
Number of shares, derivatives
PARTICIPATION IN DIVIDEND or other financial instruments
REINVESTMENT PLAN RELATING linked to them acquired
TO FINAL DIVIDEND FOR YEAR
7 END 30 SEPTEMBER 2011 8 16,789
----------------------------------------- --- -------------------------------------------
Price per share or derivative
Number of shares, derivatives or other financial instrument
or other financial instruments linked to them or value of transaction
linked to them disposed of
9 N/A 10 EUR2.198226
----------------------------------------- --- -------------------------------------------
Date and place of transaction
Date issuer informed of transaction
20 FEBRUARY - 1 MARCH 2012
11 DUBLIN, LONDON 12 1 MARCH 2012
----------------------------------------- --- -------------------------------------------
Name of contact and telephone
number for queries
Any additional information
KAREN GEOGHEGAN
13 N/A 14 + 353 1 463 7720
----------------------------------------- --- -------------------------------------------
Name and signature of duly designated officer of issuer responsible
for making notification
KAREN GEOGHEGAN_____________________________
Date of notification 1 MARCH 2012___________________
--- -------------------------------------------------------------------------------------------
The following information is required under the Irish Stock
Exchange's Listing Rule 6.10.
An issuer is not required to submit the following information to
the Central Bank of Ireland.
15 Description of class of 16 Percentage of issued class acquired
share (treasury shares of that class should
not be taken into account when calculating
percentage)
ORDINARY SHARES 0.007%
Percentage of issued class Total holding following notification
disposed (treasury shares and total percentage holding following
of that class should not notification (any treasury shares
be taken into account when should not be taken into account
calculating percentage) when calculating percentage)
17 N/A 18 787,380 (0.32%)
---------------------------- --- --------------------------------------------
If a person discharging managerial responsibilities has been
granted options by the issuer, please complete the following
boxes:
Date of grant Period during which or date on which
it can be exercised
19 N/A 20 N/A
Description of shares involved (class
Total amount paid (if any) and number)
for grant of the option
21 N/A 22 N/A
--------------------------------- --- -----------------------------------------
23 Exercise price (if fixed 24 Total number of shares over which
at time of grant) or indication options are held following notification
that the price is to be
fixed at the time of exercise
N/A
N/A
--------------------------------- --- -----------------------------------------
This announcement has been issued through the Companies
Announcement Service of
The Irish Stock Exchange.
This information is provided by RNS
The company news service from the London Stock Exchange
END
ISEUAOBRUAAORAR
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Apr 2023 to Apr 2024
